Yuki Kyoda, Makoto Kimura, Takashi Shimizu, Noriomi Miyao, Takuto Ogasawara, Toshiaki Shimizu, Akihiko Iwasawa, Wakako Yorozuya, Jiro Hashimoto, Koji Ichihara, Fumiyasu Takei, Kosuke Uchida, Nodoka Kouzen, Noriyoshi Suzuki, Kimihito Tachikawa, Akihiko Shibuya, Ippei Muranaka, Manabu Okada, Manabu Igarashi, Kosuke Shibamori, Seisuke Nofuji, Keiko Fujino, Tomohiro Toyota, Yu Ito, Nobuo Shinkai, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori
OBJECTIVES: To clarify Japanese real-world clinical data on the use of desmopressin 25 and 50 μg orally disintegrating tablets (ODT) for male patients with nocturia and evaluate the predictive factors to improve nighttime frequency. METHODS: We retrospectively accumulated real-world clinical data from 27 institutions in Japan. Male patients with two or more episodes of nocturia who received desmopressin ODT for nocturnal polyuria (NP) from 2019 through 2021 were included...
November 2022: Lower Urinary Tract Symptoms